MOA Survey and Feedback 

How can Component Societies better provide value to their members? 


The MOA instituted a Restructuring Task Force early in the year under Past President, Stephen Bell, DO, to help us determine the best way to communicate and interact with our members as technology evolves. The following survey is seeking feedback on how our Component Societies can better meet the needs of their member physicians. This survey will be used to gather information that will provide direction to the MOA and its components moving forward. 

Survey link: 

Please take a moment of your time to assist us with this task. Your feedback as a member is greatly appreciated. 

Andrew D. Adair, DO, FAAFP, FACOFP
President of the Michigan Osteopathic Association


  • On September 11, 2023, the U.S. Food & Drug Administration (FDA) took action to approve and authorize updated COVID-19 vaccines formulated to more closely target currently circulating variants and provide better protection against serious consequences to COVID-19, including hospitalization and death. These actions relate to the updated mRNA vaccines for 2023-2024 manufactured by Moderna and Pfizer-BioNTech. 
  • An important note: Bivalent mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccines are NO LONGER authorized for use in the United States, per the FDA press release.
  • ACIP and CDC will issue additional guidance (including recommendations for use) Tuesday, September 12 following the ACIP meeting. MDHHS will share this information once it becomes available.
  • As we wait for ordering of the updated 2023-2024 monovalent COVID-19 vaccines to begin, there will be a short period when vaccination with mRNA COVID-19 vaccines will not occur.  
  • We anticipate the updated 2023-2024 vaccine will be available in the near future. 
  • At this time, MCIR does not reflect assessment and forecasting for the updated monovalent COVID-19 vaccines, once CDC clinical guidance is shared, MCIR will be programmed to reflect the updated monovalent vaccine.



  • The US Government will end distribution of COVID-19 vaccines through the current ordering system beginning September 12, 2023. Because the Bivalent mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccines are NO LONGER authorized for use in the United States, they should no longer be administered. Providers should maintain their inventories until further guidance is provided.
  • Any vial of vaccine that exceeds the shelf-life indicated by the manufacturer should be disposed in accordance with local regulations and processes currently being used to dispose of regulated medical waste.

Additional information on the transition to commercialized COVID-19 vaccine is forthcoming and will be shared as it becomes available. MDHHS appreciates your patience as we navigate this change.

If you have questions, please contact [email protected]. 

Thank you, 
MDHHS Division of Immunization

Economic Impact of Healthcare

The Economic Impact of Healthcare in Michigan report, available at, is a collaborative report of the Partnership for Michigan’s Health, comprised of the Michigan Health & Hospital Association, the Michigan Osteopathic Association, and the Michigan State Medical Society. The report is based on 2021 data from the American Hospital Association and the data modeling program of IMPLAN, which uses data from sources such as the U.S. Bureau of Economic Analysis, the U.S. Bureau of Labor Statistics and the U.S. Census Bureau. The report’s dashboard provides statewide data and breaks it down by region, county and congressional district.

Economic Impact of Healthcare in Michigan

Medicaid - COVID-19 Public Health Emergency (PHE) Ending Resources

During the federal COVID-19 Public Health Emergency (PHE), many changes were made to the Medicaid program's eligibility, administration, and policies to ease rules for providers and prevent Medicaid beneficiaries from losing their healthcare coverage.  It is anticipated that the US Department of Health and Human Services will soon announce the end of the current federal PHE. Michigan will restart Medicaid eligibility renewals and certain waived policies that were in place during the pandemic when the federal PHE ends. [CONTINUE TO MDHHS ANNOUNCEMENT, FAQ's AND RESOURCES]






Multiview advertisement


ACEMAPP connects employers with professionals with job opportunities in the Great Lakes region. Employers include private practices, hospitals, health systems, community health centers, federally qualified health clinics, specialty practices, prison health, and telemedicine providers. Available locations range from rural to urban areas, and many opportunities qualify for loan repayment.
Search Jobs
Post Jobs

Opioid Prescribers' Legislative Alert

On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. The MOA is part of a coalition that is working with the Department of Health and Human Services (MDHHS) to provide input from healthcare professionals in regards to the laws, regulations and systems used by prescribers. 

For MOA members, a page has been created with an overview, a link to a summary (PDF) and a link to a survey designed to get feedback from the MOA membership.

Opioid Alert page (MOA login page)
Michigan Automated Prescription System (MAPS) - User Support Manual